eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2017
vol. 21
 
Share:
Share:
abstract:
Review paper

Immune checkpoints, their control by immunotherapy and ovarian cancer

Chinmoy K. Bose

Contemp Oncol (Pozn) 2017; 21 (3): 189-196
Online publish date: 2017/09/29
View full text Get citation
 
PlumX metrics:
Immune checkpoints are new targets for manipulation of immunological control over malignant tumors. They provide an important means to manage especially recurrent and refractory cancers and those cancers where there is an unmet need such as recurrent melanoma, renal cell carcinoma and recurrent ovarian cancer. As a new development this subject is experiencing rapid progress and multiple avenues are opening up. However, there are many hurdles to overcome, requiring constant updating, especially for students of ovarian cancer, who are looking at it with much hope.
keywords:

immune checkpoint, T cell, ovarian cancer

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.